The V89L polymorphism in the 5α-reductase type 2 gene and risk of prostate cancer

PG Febbo, PW Kantoff, EA Platz, D Casey, S Batter… - Cancer research, 1999 - AACR
Abstract 5α-Reductase type 2, the predominant prostatic isozyme of this protein, converts
testosterone to dihydrotestosterone. It has been hypothesized that individuals with greater …
被引用次数：113 相关文章

[引用][C] The V89L polymorphism in the 5α-reductase type 2 gene and risk of prostate cancer

PG FEBBO, PW KANTOFF, EA PLATZ… - Cancer research …, 1999 - pascal-francis.inist.fr
The V89L polymorphism in the 5α-reductase type 2 gene and risk of prostate cancer CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …

[引用][C] The V89L polymorphism in the 5 alpha-reductase type 2 gene and risk of prostate cancer

F PG - Cancer Res, 1999 - cir.nii.ac.jp
[PDF] researchgate.net

[PDF][PDF] The V89L Polymorphism in the 5

PG Febbo, PW Kantoff, EA Platz - CANCER RESEARCH, 1999 - researchgate.net
Reductase type 2, the predominant prostatic isozyme of this protein, converts testosterone to
dihydrotestosterone. It has been hypothesized that individuals with greater 5-reductase …

The V89L polymorphism in the 5α-reductase type 2 gene and risk of prostate cancer

PG Febbo, PW Kantoff, EA Platz, D Casey… - Cancer …, 1999 - pure.johnshopkins.edu
Abstract 5α-Reductase type 2, the predominant prostatic isozyme of this protein, converts
testosterone to dihydrotestosterone. It has been hypothesized that individuals with greater …

The V89L polymorphism in the 5alpha-reductase type 2 gene and risk of prostate cancer

PG Febbo, PW Kantoff, EA Platz, D Casey… - Cancer …, 1999 - pubmed.ncbi.nlm.nih.gov
5alpha-Reductase type 2, the predominant prostatic isozyme of this protein, converts
testosterone to dihydrotestosterone. It has been hypothesized that individuals with greater …

The V89L polymorphism in the 5α-reductase type 2 gene and risk of prostate cancer

PG Febbo, PW Kantoff, EA Platz, D Casey… - Cancer …, 1999 - ohsu.elsevierpure.com
Abstract 5α-Reductase type 2, the predominant prostatic isozyme of this protein, converts
testosterone to dihydrotestosterone. It has been hypothesized that individuals with greater …

The V89L polymorphism in the 5alpha-reductase type 2 gene and risk of prostate cancer.

PG Febbo, PW Kantoff, EA Platz, D Casey… - Cancer …, 1999 - europepmc.org
5alpha-Reductase type 2, the predominant prostatic isozyme of this protein, converts
testosterone to dihydrotestosterone. It has been hypothesized that individuals with greater …

[引用][C] The V89L polymorphism in the 5α-reductase type 2 gene and risk of prostate cancer

PG FEBBO, PW KANTOFF… - Cancer …, 1999 - American Association for Cancer …